Jw Pharmac Cash Flow Conversion Efficiency

Latest as of March 2026: 0.046x

Jw Pharmac cash flow conversion efficiency. Based on the latest financial reports, Jw Pharmac (001060) has a cash flow conversion efficiency ratio of 0.046x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩17.50 Billion ≈ $11.86 Million USD) by net assets (₩381.78 Billion ≈ $258.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Jw Pharmac (2001–2025)

Cash flow conversion efficiency of Jw Pharmac from 2001 to 2025. This chart illustrates how Jw Pharmac's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Jw Pharmac stock quote for real-time trading data and today's change.

Jw Pharmac Cash Flow Conversion Ratio Explained

Jw Pharmac cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jw Pharmac Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jw Pharmac ranked by their cash flow conversion efficiency. Also see how much is Jw Pharmac worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Zhenhai PetroChem Engineering SHG:603637	0.031x
Jiayuan Science and Technology Co.Ltd. SHE:301117	N/A
Haleon PLC LSE:HLN	0.032x
WhiteFiber, Inc. Ordinary Shares NASDAQ:WYFI	-0.035x
Tidewater Midstream and Infrastructure Ltd TO:TWM	-0.025x
Komipharm International Co. Ltd KQ:041960	0.013x
Roma Green Finance Limited Ordinary Shares NASDAQ:ROMA	-0.087x
Wuhan Ligong Guangke Co Ltd SHE:300557	0.008x

Annual Cash Flow Conversion Efficiency for Jw Pharmac (2001–2025)

The table below shows the annual cash flow conversion efficiency of Jw Pharmac from 2001 to 2025. Review 001060 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩369.37 Billion ≈ $250.32 Million	₩96.40 Billion ≈ $65.33 Million	0.261x	+8.31%
2024-12-31	₩329.49 Billion ≈ $223.29 Million	₩79.39 Billion ≈ $53.80 Million	0.241x	-26.62%
2023-12-31	₩265.44 Billion ≈ $179.89 Million	₩87.16 Billion ≈ $59.07 Million	0.328x	+30.59%
2022-12-31	₩225.76 Billion ≈ $152.99 Million	₩56.76 Billion ≈ $38.47 Million	0.251x	+161.57%
2021-12-31	₩188.54 Billion ≈ $127.77 Million	₩18.12 Billion ≈ $12.28 Million	0.096x	-68.37%
2020-12-31	₩207.47 Billion ≈ $140.60 Million	₩63.05 Billion ≈ $42.73 Million	0.304x	+25.93%
2019-12-31	₩230.09 Billion ≈ $155.93 Million	₩55.53 Billion ≈ $37.63 Million	0.241x	+20.47%
2018-12-31	₩260.11 Billion ≈ $176.27 Million	₩52.11 Billion ≈ $35.31 Million	0.200x	+62.17%
2017-12-31	₩270.78 Billion ≈ $183.50 Million	₩33.45 Billion ≈ $22.67 Million	0.124x	+406.54%
2016-12-31	₩276.31 Billion ≈ $187.25 Million	₩6.74 Billion ≈ $4.57 Million	0.024x	+231.67%
2015-12-31	₩225.41 Billion ≈ $152.75 Million	₩-4.17 Billion ≈ $-2.83 Million	-0.019x	-156.95%
2014-12-31	₩223.83 Billion ≈ $151.68 Million	₩7.28 Billion ≈ $4.93 Million	0.033x	-65.14%
2013-12-31	₩200.74 Billion ≈ $136.04 Million	₩18.72 Billion ≈ $12.69 Million	0.093x	-76.23%
2012-12-31	₩163.66 Billion ≈ $110.91 Million	₩64.21 Billion ≈ $43.52 Million	0.392x	+1233.92%
2006-12-31	₩172.48 Billion ≈ $116.89 Million	₩5.07 Billion ≈ $3.44 Million	0.029x	-95.00%
2005-12-31	₩119.44 Billion ≈ $80.95 Million	₩70.25 Billion ≈ $47.61 Million	0.588x	+367.61%
2004-12-31	₩119.39 Billion ≈ $80.91 Million	₩15.02 Billion ≈ $10.18 Million	0.126x	-16.92%
2003-12-31	₩112.60 Billion ≈ $76.31 Million	₩17.05 Billion ≈ $11.55 Million	0.151x	-46.93%
2002-12-31	₩100.72 Billion ≈ $68.26 Million	₩28.74 Billion ≈ $19.47 Million	0.285x	-43.68%
2001-12-31	₩88.92 Billion ≈ $60.26 Million	₩45.04 Billion ≈ $30.52 Million	0.507x	--

About Jw Pharmac

KO:001060 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$349.95 Million

₩516.38 Billion KRW

Market Cap Rank

#13794 Global

#415 in Korea

Share Price

₩22900.00

Change (1 day)

-0.43%

52-Week Range

₩22000.00 - ₩39050.00

All Time High

₩75306.05